Venbio Partners LLC’s Akero Therapeutics Inc Com Position
Does Venbio Partners LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 596.5K shares worth $20M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$20M
Q3 2022
Shares
596.5K
% of Portfolio
+4.70%
Quarters Held
13
position exited
Position History AKRO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 596.5K | $20M | +4.70% |
| Q2 2022 | 2.17M | $21M | +5.84% |
| Q1 2022 | 2.17M | $31M | +6.83% |
| Q4 2021 | 2.17M | $46M | +8.28% |
| Q3 2021 | 2.20M | $49M | +4.90% |
| Q2 2021 | 2.20M | $55M | +6.44% |
| Q1 2021 | 2.44M | $71M | +6.74% |
| Q4 2020 | 2.44M | $63M | +5.57% |
| Q3 2020 | 2.44M | $75M | +11.44% |
| Q2 2020 | 3.15M | $78M | +65.27% |
| Q4 2019 | 3.94M | $87M | +37.50% |
| Q3 2019 | 3.95M | $90M | +42.68% |
| Q2 2019 | 3.95M | $76M | +33.61% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venbio Partners LLC’s full portfolio or all institutional holders of AKRO.